Still A COVID-19 Game Changer? UK’s Cautious Launch Of MSD’s Antiviral Lagevrio

Efficacy In Vaccinated Population Unproven

 
• By Andrew McConaghie
  
UK oovid December 2021
The Lagevrio study coincides with the UK re-introducing social distancing measures to limit the effects of the new Omicron variant. • Source: Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D